SMAD3 and Hepatic fibrosis: D-carvone attenuated CCl4-induced liver fibrosis by deterring oxidative stress and the TGF-ß 1/SMAD3 pathway, which presented the compound as a possible candidate for inhibiting liver fibrosis, as well as other oxidative stress-related hepatic diseases [16].